The FDA has approved Otarmeni, the first-ever gene therapy for genetic hearing loss caused by the OTOF gene, for both ...

Artificial intelligence (AI) and machine learning (ML) systems have become central to modern data-driven decision-making. They are now widely applied in fields as diverse as healthcare, finance, ...

Insurance AI isn't just about the model; it’s about building a "beast" of a backbone that can process thousands of pages in ...

Data teams building AI agents keep running into the same failure mode. Questions that require joining structured data with ...

Welcome to another installment of This Week at FDA, your weekly source for updates – big and small – on FDA, drug and medical ...

Heterogeneous NPU designs bring together multiple specialized compute engines to support the range of operators required by ...

This week’s Web3 Thoughts of the Week tackles DoorDash and stablecoins, spot Bitcoin ETFs, and DeFi’s tattered image.

Modality-agnostic decoders leverage modality-invariant representations in human subjects' brain activity to predict stimuli irrespective of their modality (image, text, mental imagery).

The study offers a valuable resource and integrates multiple complementary datasets to provide insights into regulatory mechanisms, although the conceptual advances are moderate and the central ...

Enterprise AI may have moved beyond the proof of concept phase, but many companies still seem stuck in the same place ...